GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 251 filers reported holding GLOBUS MED INC in Q3 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $81,000 | +12.5% | 1,694 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $72,000 | -28.0% | 1,694 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $100,000 | -60.0% | 1,694 | -65.4% | 0.01% | -66.7% |
| Q3 2019 | $250,000 | +23.8% | 4,897 | +2.7% | 0.02% | +25.0% |
| Q2 2019 | $202,000 | -17.6% | 4,769 | -3.9% | 0.01% | -20.0% |
| Q1 2019 | $245,000 | +14.5% | 4,961 | +0.2% | 0.02% | 0.0% |
| Q4 2018 | $214,000 | -10.8% | 4,950 | +16.9% | 0.02% | +7.1% |
| Q3 2018 | $240,000 | -3.2% | 4,235 | -14.0% | 0.01% | -6.7% |
| Q2 2018 | $248,000 | +3.3% | 4,924 | +2.2% | 0.02% | +7.1% |
| Q1 2018 | $240,000 | +4.8% | 4,820 | -13.7% | 0.01% | +7.7% |
| Q4 2017 | $229,000 | +141.1% | 5,583 | +74.6% | 0.01% | +116.7% |
| Q3 2017 | $95,000 | -53.4% | 3,198 | -48.0% | 0.01% | -50.0% |
| Q2 2017 | $204,000 | +33.3% | 6,152 | +19.3% | 0.01% | +20.0% |
| Q1 2017 | $153,000 | +15.0% | 5,157 | -3.7% | 0.01% | +11.1% |
| Q4 2016 | $133,000 | – | 5,353 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |